Optimal risk assessment for primary prevention remains highly challenging. Recent
registries have highlighted major discrepancies between guidelines and daily practice …

Objective To systematically review the safety and the long-term mortality and morbidity risk-
rates of the remotely-delivered cardiac rehabilitation (RDCR) interventions in coronary heart …

Despite the advances in treatment options, cardiovascular disease (CVDs) remains the
leading cause of death over the world. Chronic inflammatory response and irreversible …

Cardiovascular disease (CVD) disproportionately affects ethnic minority groups globally.
Ethnic minority groups face particularly high CVD burden and mortality, exacerbated by …

The growing prevalence of cardiovascular diseases in the United States (US) has
disproportionately affected minority populations more than their white counterparts. A …

Cardiovascular disease is the leading cause of death worldwide, and it commonly results
from atherosclerotic plaque progression. One of the increasingly recognized drivers of …

IL-6 mediated inflammation most likely causes ASCVD, in parallel with LDL cholesterol.
However, fewer individuals in the general population are exposed to high IL-6 than high …

Atherosclerosis, a chronic inflammatory disease characterized by arterial plaque
accumulation, remains a significant global health challenge. In recent years …

Myocardial injury causes death to cardiomyocytes and leads to heart failure. The adult
mammalian heart has very limited regenerative capacity. However, the heart from early …

Cardiovascular disease is a leading cause of death worldwide. Loss of cardiomyocytes that
occurs during many types of damage to the heart such as ischemic injury and stress caused …